These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9247664)

  • 1. Recommendations for the reliable detection of illicit drugs in urine in the European Union, with special attention to the workplace. EU Toxicology Experts working Group.
    de la Torre R; Segura J; de Zeeuw R; Williams J
    Ann Clin Biochem; 1997 Jul; 34 ( Pt 4)():339-44. PubMed ID: 9247664
    [No Abstract]   [Full Text] [Related]  

  • 2. Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry.
    Goldberger BA; Cone EJ
    J Chromatogr A; 1994 Jul; 674(1-2):73-86. PubMed ID: 8075776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
    Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
    J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of illicit drugs by truck drivers arriving at Paranaguá port terminal, Brazil.
    Peixe TS; de Almeida RM; Girotto E; de Andrade SM; Mesas AE
    Traffic Inj Prev; 2014; 15(7):673-7. PubMed ID: 24313348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of drugs-of-abuse testing in urine: An AACC study.
    Frings CS; White RM; Battaglia DJ
    Clin Chem; 1987 Sep; 33(9):1683-6. PubMed ID: 3621586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the reliable detection of illicit drugs in urine, with special attention to the workplace, in the European Union (December 1996). The Toxicology Experts' Working Group.
    Killander J; de la Torre R; Segura J; de Zeeuw R; Williams J
    Scand J Clin Lab Invest; 1997 Apr; 57(2):97-103. PubMed ID: 9200267
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European guidelines for workplace drug testing in urine.
    Taskinen S; Beck O; Bosch T; Brcak M; Carmichael D; Fucci N; George C; Piper M; Salomone A; Schielen W; Steinmeyer S; Weinmann W
    Drug Test Anal; 2017 Jun; 9(6):853-865. PubMed ID: 28267298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing false-negative tests in urinary drugs-of-abuse screening.
    Luceri F; Godi F; Messeri G
    J Anal Toxicol; 1997; 21(3):244-5. PubMed ID: 9171214
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a human on-site urine multidrug test for emergency use with dogs.
    Teitler JB
    J Am Anim Hosp Assoc; 2009; 45(2):59-66. PubMed ID: 19258416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatinine normalization of workplace urine drug tests: does it make a difference?
    Price JW
    J Addict Med; 2013; 7(2):129-32. PubMed ID: 23370934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive cannabis results in Italian workplace drug testing.
    Fucci N; De Giovanni N
    Drug Test Anal; 2012 Feb; 4(2):71-3. PubMed ID: 22362572
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
    Korte T; Pykäläinen J; Lillsunde P; Seppälä T
    J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine, cocaine and cannabinoids use among truck drivers on the roads in the State of Sao Paulo, Brazil.
    Leyton V; Sinagawa DM; Oliveira KC; Schmitz W; Andreuccetti G; De Martinis BS; Yonamine M; Munoz DR
    Forensic Sci Int; 2012 Feb; 215(1-3):25-7. PubMed ID: 21511416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of urinary drugs of abuse by a multianalyte capillary electrophoretic immunoassay.
    Caslavska J; Allemann D; Thormann W
    J Chromatogr A; 1999 Apr; 838(1-2):197-211. PubMed ID: 10327639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of DRI, CEDIA, and REMEDi systems for preliminary tests of amphetamines and opiates in human urine.
    Huang MK; Dai YS; Lee CH; Liu C; Tsay WI; Li JH
    J Anal Toxicol; 2006; 30(1):61-4. PubMed ID: 16620534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.